nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A complement-dependent human long-noncoding RNA induced by Staphylococcus aureus
|
Karlsen, Bård O. |
|
2017 |
89 |
C |
p. 151- 1 p. |
artikel |
2 |
Acquisition of C1 inhibitor by Bordetella pertussis Vag8 results in C2 and C4 consumption away from the bacterial surface
|
Hovingh, Elise S. |
|
2017 |
89 |
C |
p. 152-153 2 p. |
artikel |
3 |
A cryptic non-GPI anchored form of CD59 facilitates insulin secretion from pancreatic beta cells
|
King, Ben C. |
|
2017 |
89 |
C |
p. 135- 1 p. |
artikel |
4 |
Activation of alternative complement pathway without complement factor D
|
Zhang, Yuzhou |
|
2017 |
89 |
C |
p. 173- 1 p. |
artikel |
5 |
Activation of complement by pigment epithelium-derived factor (PEDF) in rheumatoid arthritis
|
Vogt, Leonie M. |
|
2017 |
89 |
C |
p. 116-117 2 p. |
artikel |
6 |
Activation of C1, the complex initiating the classical pathway of the complement cascade, through cross-complex activation of proteases
|
Thiel, Steffen |
|
2017 |
89 |
C |
p. 141-142 2 p. |
artikel |
7 |
Activation of the alternative pathway of complement, represented by factor Bb, is longitudinally associated with late β-cell conservation in type 2 diabetes: The CODAM study
|
van Greevenbroek, Marleen |
|
2017 |
89 |
C |
p. 189- 1 p. |
artikel |
8 |
Administration of intravenous iron preparations induces complement activation in anemic patients
|
Faria, B. |
|
2017 |
89 |
C |
p. 180- 1 p. |
artikel |
9 |
Altered expression of complement factors in patients with nasal polyps in response to the TLR3 ligand PolyI:C
|
Werner, Ulrike |
|
2017 |
89 |
C |
p. 138-139 2 p. |
artikel |
10 |
A multi-center method comparison for detection of autoantibodies to human complement Factor H (AFH)
|
Willrich, Maria Alice |
|
2017 |
89 |
C |
p. 118- 1 p. |
artikel |
11 |
Analysis of C3 gene variants in patients with idiopathic, recurrent, spontaneous pregnancy loss
|
Mohlin, Frida C. |
|
2017 |
89 |
C |
p. 147- 1 p. |
artikel |
12 |
Analysis of complement gene variants in the clinical laboratory: Comparison of Next-Generation Sequencing (NGS) and Sanger methods
|
Lagerstedt, Susan A. |
|
2017 |
89 |
C |
p. 149- 1 p. |
artikel |
13 |
Analysis of Factor D isoforms in 3MC patients highlights the role of MASP-3 as a maturase in the alternative pathway of complement
|
Pihl, Rasmus |
|
2017 |
89 |
C |
p. 144- 1 p. |
artikel |
14 |
A new complement evasion strategy: How S. pyogenes exploits IgGs to recruit more C4BP
|
Ermert, David |
|
2017 |
89 |
C |
p. 155- 1 p. |
artikel |
15 |
A novel endothelial cell based complement dependent cytotoxicity test in kidney transplantation
|
Lammerts, R.G.M. |
|
2017 |
89 |
C |
p. 209- 1 p. |
artikel |
16 |
A novel model for complement studies and intervention in kidney ischemia/reperfusion injury
|
Schjalm, Camilla |
|
2017 |
89 |
C |
p. 208-209 2 p. |
artikel |
17 |
A novel nanobody inhibitor of the alternative pathway
|
Jensen, Rasmus Kjeldsen |
|
2017 |
89 |
C |
p. 198- 1 p. |
artikel |
18 |
Anti-factor H autoantibodies in Tunisian aHUS patients
|
Sellami, M. Kallel |
|
2017 |
89 |
C |
p. 184- 1 p. |
artikel |
19 |
Anti-H-factor autoantibodies in inflammatory myopathies
|
Marie, Senant |
|
2017 |
89 |
C |
p. 119- 1 p. |
artikel |
20 |
Antimicrobial peptides of invertebrates influence on the complement activity
|
Umnyakova, Ekaterina S. |
|
2017 |
89 |
C |
p. 196- 1 p. |
artikel |
21 |
APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria
|
Mehdi, Delphine El |
|
2017 |
89 |
C |
p. 115- 1 p. |
artikel |
22 |
A protective role of complement regulators linked to a PEG phospholipid construct in reducing ischemic reperfusion injury in transplantation
|
Nilsson, Bo |
|
2017 |
89 |
C |
p. 208- 1 p. |
artikel |
23 |
Assessment of complement and NK cell activation in GalTKO/hCD46/HLA-E porcine hearts ex vivo xenoperfused with human blood
|
Rieben, Robert |
|
2017 |
89 |
C |
p. 207- 1 p. |
artikel |
24 |
Association of lectin pathway protein levels and genetic variants early after injury with outcomes after severe traumatic brain injury. A prospective cohort study
|
Trendelenburg, Marten |
|
2017 |
89 |
C |
p. 212-213 2 p. |
artikel |
25 |
Associations of the alternative pathway and classical pathway of complement activation with incident metabolic syndrome: The CODAM study
|
Xin, Ying |
|
2017 |
89 |
C |
p. 190- 1 p. |
artikel |
26 |
A teenager with primary pneumococcal peritonitis
|
Ugrinovic, S. |
|
2017 |
89 |
C |
p. 156- 1 p. |
artikel |
27 |
Atypical hemolytic uremic syndrome – Why the kidney?
|
Roumenina, Lubka T. |
|
2017 |
89 |
C |
p. 172-173 2 p. |
artikel |
28 |
Author Index
|
|
|
2017 |
89 |
C |
p. I-VI nvt p. |
artikel |
29 |
Auto-regulation of Th1 responses through carboxypeptidase M-generated C5a-desArg
|
West, Erin E. |
|
2017 |
89 |
C |
p. 135- 1 p. |
artikel |
30 |
BET inhibitor apabetalone (RVX-208) downregulates the complement cascade in primary human hepatocytes, in mice and in cardiovascular disease human patients
|
Wasiak, Sylwia |
|
2017 |
89 |
C |
p. 127-128 2 p. |
artikel |
31 |
Binding of von Willebrand factor to complement C1q on a cholesterol crystal surface
|
Donat, Claudia |
|
2017 |
89 |
C |
p. 137- 1 p. |
artikel |
32 |
Binding to complement receptor 1 affects the growth of Staphylococcus aureus in fresh human whole blood
|
Dahl, J.A. |
|
2017 |
89 |
C |
p. 170- 1 p. |
artikel |
33 |
Blood levels of glycated CD59 (GCD59), a novel biomarker in diabetes, predict pregnancy-induced glucose intolerance
|
Halperin, Jose |
|
2017 |
89 |
C |
p. 188- 1 p. |
artikel |
34 |
Candida albicans battles the Dectin-1 and Dectin-2 mediated host-immune response
|
Reiher, Nadine |
|
2017 |
89 |
C |
p. 157- 1 p. |
artikel |
35 |
CD40 ligation on antigen presenting cells (APCs) enhances properdin production
|
van Essen, Mieke |
|
2017 |
89 |
C |
p. 132- 1 p. |
artikel |
36 |
Cell-type specific complement expression in aging, albino mice
|
Pauly, Diana |
|
2017 |
89 |
C |
p. 190- 1 p. |
artikel |
37 |
Cell type-specific phosphokinetics for central intracellular signal transducers downstream of pattern recognition signaling by E. coli-induced inflammation in human whole blood
|
Lau, Corinna |
|
2017 |
89 |
C |
p. 168- 1 p. |
artikel |
38 |
CFHR5 binds to MAA-epitopes exposed on the surface of modified human endothelial cells
|
Rudnick, Ramona B. |
|
2017 |
89 |
C |
p. 196- 1 p. |
artikel |
39 |
Characterization of a novel whole blood model for the study of thrombin in complement activation and inflammation
|
Nilsson, Per H. |
|
2017 |
89 |
C |
p. 136-137 2 p. |
artikel |
40 |
Characterization of collectin LK, CL-LK
|
Hansen, Soren W.K. |
|
2017 |
89 |
C |
p. 190-191 2 p. |
artikel |
41 |
Characterization of complement components in a Spanish cohort of ANCA-associated vasculitis
|
Gutierrez-Tenorio, Josue |
|
2017 |
89 |
C |
p. 116- 1 p. |
artikel |
42 |
C1-inhibitor treatment decreases renal injury in an established brain-dead rat model
|
Jager, N.M. |
|
2017 |
89 |
C |
p. 211- 1 p. |
artikel |
43 |
CL-11 in systemic inflammatory response syndrome
|
Bayarri-Olmos, Rafael |
|
2017 |
89 |
C |
p. 169- 1 p. |
artikel |
44 |
Clot formation is enhanced by complement activation in a microvascular flow model
|
Jenny, Lorenz |
|
2017 |
89 |
C |
p. 133- 1 p. |
artikel |
45 |
Combined C5aR1 and CD14 inhibition significantly reduced cytokine release induced by both viable and heat inactivated bacteria in human whole blood
|
Christiansen, Dorte |
|
2017 |
89 |
C |
p. 169-170 2 p. |
artikel |
46 |
Combined inhibition of C5 and CD14 attenuates systemic inflammation in a newborn pig-model of meconium aspiration syndrome
|
Thomas, Anub Mathew |
|
2017 |
89 |
C |
p. 166-167 2 p. |
artikel |
47 |
Complement activation fragment C4a acts as effector molecule by signaling via protease-activated receptors 1 and 4
|
Ricklin, Daniel |
|
2017 |
89 |
C |
p. 130- 1 p. |
artikel |
48 |
Complement anaphylatoxin receptors have critical physiological functions in the developing mammalian brain
|
Woodruff, Trent M. |
|
2017 |
89 |
C |
p. 185-186 2 p. |
artikel |
49 |
Complement and coagulation is activated in periodontitis in acute intermittent porphyria
|
Storjord, Elin |
|
2017 |
89 |
C |
p. 131-132 2 p. |
artikel |
50 |
Complement biomarkers in Alzheimer's disease
|
Morgan, Angharad R. |
|
2017 |
89 |
C |
p. 187- 1 p. |
artikel |
51 |
Complement component C3 is highly expressed in human pancreatic islets and promotes β-cell survival
|
Kulak, Klaudia |
|
2017 |
89 |
C |
p. 137- 1 p. |
artikel |
52 |
Complement C5, phagocytosis and Toll-like receptor 4 play key roles in Escherichia coli-induced surface expression of tissue factor on human monocytes
|
Landsem, Anne |
|
2017 |
89 |
C |
p. 138- 1 p. |
artikel |
53 |
Complement endorse the pathogenesis in autoinflammation
|
Brunner, Jürgen |
|
2017 |
89 |
C |
p. 119- 1 p. |
artikel |
54 |
Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, Sub-Saharan Africa: Implications for the susceptibility to meningococcal disease
|
Franco-Jarava, Clara |
|
2017 |
89 |
C |
p. 158-159 2 p. |
artikel |
55 |
Complement factor H and the long pentraxin PTX3 cooperate in the immune response to Aspergillus fumigatus
|
Inforzato, Antonio |
|
2017 |
89 |
C |
p. 156- 1 p. |
artikel |
56 |
Complement factor H-related (CFHR) proteins 2 and 5 as well as iC3b and properdin are deposited in different glomerular diseases
|
Person, Fermin |
|
2017 |
89 |
C |
p. 183- 1 p. |
artikel |
57 |
Complement factors C4 and C3 are down regulated in response to short term overfeeding in healthy young men
|
Foghmar, Caroline |
|
2017 |
89 |
C |
p. 136- 1 p. |
artikel |
58 |
Complement in clinical medicine: Clinical trials, case reports and therapy monitoring
|
Ricklin, Daniel |
|
2017 |
89 |
C |
p. 10-21 12 p. |
artikel |
59 |
Complement inhibition during brain death to improve the quality of thoracic organs: Which pathway(s) has potential?
|
van Zanden, J.E. |
|
2017 |
89 |
C |
p. 211- 1 p. |
artikel |
60 |
Complement inhibitor CSMD1 acts as a tumor suppressor in breast cancer by interacting with EGF receptor
|
Gialeli, Chrysostomi |
|
2017 |
89 |
C |
p. 123- 1 p. |
artikel |
61 |
Complement in renal transplantation: The road to translation
|
Jager, Neeltina M. |
|
2017 |
89 |
C |
p. 22-35 14 p. |
artikel |
62 |
Complement interaction with cells undergoing immunogenic cell death
|
Noe, Remi |
|
2017 |
89 |
C |
p. 122- 1 p. |
artikel |
63 |
Complement markers in immunoadsorption combined with membrane filtration for antibody-mediated rejection kidney transplantation
|
Defendi, Federica |
|
2017 |
89 |
C |
p. 210- 1 p. |
artikel |
64 |
Complement MASP-1 induced transcriptomic changes in the inflammation-related gene expression in endothelial cells
|
Németh, Zsuzsanna |
|
2017 |
89 |
C |
p. 165- 1 p. |
artikel |
65 |
Complement profile and autoantibodies against adipocytes on acquired lipodystrophies
|
Corvillo, Fernando |
|
2017 |
89 |
C |
p. 120- 1 p. |
artikel |
66 |
Complement receptor 3 mediates TGFβ-1 comprising extracellular vesicles in human monocytes
|
Halder, Luke D. |
|
2017 |
89 |
C |
p. 162- 1 p. |
artikel |
67 |
Complement receptor 1 polymorphism is associated with cerebral malaria in two discrete populations, but no evidence that human brain endothelial cells express the molecule
|
Swann, Olivia |
|
2017 |
89 |
C |
p. 157- 1 p. |
artikel |
68 |
Complement regulator factor H and its proposed antagonists in invasive bacterial infections
|
van Beek, Anna E. |
|
2017 |
89 |
C |
p. 158- 1 p. |
artikel |
69 |
Complement system biomarkers in first episode psychosis
|
Morgan, B. Paul |
|
2017 |
89 |
C |
p. 187- 1 p. |
artikel |
70 |
Complement system proteins in human embryonic stem cell-derived retinal pigment epithelial cells co-cultured with or without porcine retina
|
Mohlin, C. |
|
2017 |
89 |
C |
p. 162-163 2 p. |
artikel |
71 |
Contribution of adipose-derived factor D/adipsin to alternative pathway complement activation: Lessons from lipodystrophy
|
Wu, Xiaobo |
|
2017 |
89 |
C |
p. 143- 1 p. |
artikel |
72 |
CORVOS – A model for a European Complement PhD (EC-PhD)
|
Würzner, Reinhard |
|
2017 |
89 |
C |
p. 192- 1 p. |
artikel |
73 |
C1q: A fresh look upon an old molecule
|
Thielens, Nicole M. |
|
2017 |
89 |
C |
p. 73-83 11 p. |
artikel |
74 |
C1QA gene mutations in a pediatric SLE cohort from North India
|
Rawat, Amit |
|
2017 |
89 |
C |
p. 117- 1 p. |
artikel |
75 |
Creating model systems to study molecular mechanisms of C5 convertase-induced Membrane Attack Complex assembly
|
Doorduijn, D.J. |
|
2017 |
89 |
C |
p. 160- 1 p. |
artikel |
76 |
Crohn's disease patients in remission display enhanced intestinal infiltration of CR2 expressing cells in concert with strong induction of the classical complement pathway
|
Derer, Stefanie |
|
2017 |
89 |
C |
p. 164-165 2 p. |
artikel |
77 |
Cyclodextrin inhibits CC-induced complement activation
|
Bakke, Siril S. |
|
2017 |
89 |
C |
p. 167-168 2 p. |
artikel |
78 |
Cysteine cathepsins L and S diminish complement activation on the surface of tumour cells
|
Hočevar, Katarina |
|
2017 |
89 |
C |
p. 122-123 2 p. |
artikel |
79 |
Deficiency of C4 from brain death mice protects against renal injury
|
Poppelaars, F. |
|
2017 |
89 |
C |
p. 207-208 2 p. |
artikel |
80 |
Defining the molecular interplay between antibodies and complement in bacterial infections
|
Zwarthoff, Seline A. |
|
2017 |
89 |
C |
p. 154-155 2 p. |
artikel |
81 |
Delivery of CR2-fH using AAV vector therapy and encapsulated cell technology as treatment strategies in mouse model of neovascularization
|
Rohrer, Bärbel |
|
2017 |
89 |
C |
p. 202- 1 p. |
artikel |
82 |
Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations
|
Tabib, Adi |
|
2017 |
89 |
C |
p. 69-72 4 p. |
artikel |
83 |
Design, expression, and function of chimeric bispecific complement inhibitors containing MAP-1 and functional domains of C4b-binding protein
|
Hertz, Cecilie Elkjær |
|
2017 |
89 |
C |
p. 165- 1 p. |
artikel |
84 |
Detection of convertase-stabilizing factors in patients with complement-mediated renal diseases: Translation to a diagnostic approach
|
Michels, Marloes |
|
2017 |
89 |
C |
p. 174-175 2 p. |
artikel |
85 |
Development of an automated assay for the measurement of C2
|
Tange, Clare |
|
2017 |
89 |
C |
p. 191- 1 p. |
artikel |
86 |
Development of an automated assay for the measurement of C1 inhibitor
|
Parker, Antony |
|
2017 |
89 |
C |
p. 191- 1 p. |
artikel |
87 |
Discovery of microRNAs regulating complement-dependent cytotoxicity
|
Hillman, Yaron |
|
2017 |
89 |
C |
p. 150- 1 p. |
artikel |
88 |
Distribution and function of the complement protein C1q in malignant pleural mesothelioma microenvironment
|
Roberta, Bulla |
|
2017 |
89 |
C |
p. 121- 1 p. |
artikel |
89 |
Dual inhibition of the lectin and alternative complement pathways efficiently protects from myocardial ischemic reperfusion related injuries
|
Skjoedt, Mikkel-Ole |
|
2017 |
89 |
C |
p. 125- 1 p. |
artikel |
90 |
Early increase of complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after stem cell transplantation
|
Horváth, Orsolya |
|
2017 |
89 |
C |
p. 210- 1 p. |
artikel |
91 |
Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses
|
Nilsson, Per H. |
|
2017 |
89 |
C |
p. 111-114 4 p. |
artikel |
92 |
Editorial Board/ Publication Information
|
|
|
2017 |
89 |
C |
p. IFC- 1 p. |
artikel |
93 |
Establishment of a complement examination system for complement-related diseases by the Japanese Association for Complement Research (JACR)
|
Hidaka, Yoshihiko |
|
2017 |
89 |
C |
p. 192- 1 p. |
artikel |
94 |
Establishment of a method for the detection of C4-nephritic factor
|
Garam, Nóra |
|
2017 |
89 |
C |
p. 182- 1 p. |
artikel |
95 |
Evaluation of mechanisms of paroxysm in paroxysmal nocturnal hemoglobinuria: In vitro explorations of “bystander” hemolysis and of perturbations of soluble regulators
|
Thanassi, Jane A. |
|
2017 |
89 |
C |
p. 204- 1 p. |
artikel |
96 |
Evaluation of risk of bacteria-mediated putative “bystander” hemolysis of PNH red blood cells in vitro: No evidence of significant complement-mediated hemolysis induced by microorganisms
|
Yang, Guangwei |
|
2017 |
89 |
C |
p. 205- 1 p. |
artikel |
97 |
Extracellular histones inhibit complement activation through interactions with complement component C4b
|
Qaddoori, Yasir |
|
2017 |
89 |
C |
p. 132- 1 p. |
artikel |
98 |
Factor H-mediated complement evasion by the infective sporozoite stages of the malaria parasite Plasmodium falciparum
|
de Araujo Rosa, Thiago Ferreira |
|
2017 |
89 |
C |
p. 153- 1 p. |
artikel |
99 |
Factor I deficiency due to homozygosity for a novel mutation in the CFI gene
|
Skattum, Lillemor |
|
2017 |
89 |
C |
p. 149- 1 p. |
artikel |
100 |
Families presenting with Carboxypeptidase N deficiency, 37 years after the single description
|
Vincent, Denis |
|
2017 |
89 |
C |
p. 194- 1 p. |
artikel |
101 |
FHR-3 drives RPE cells towards pro-inflammation
|
Schäfer, Nicole |
|
2017 |
89 |
C |
p. 143- 1 p. |
artikel |
102 |
Ficolin-2 circulating levels and intraplaque presence are associated with vulnerable atherosclerotic lesions
|
Fumagalli, Stefano |
|
2017 |
89 |
C |
p. 126- 1 p. |
artikel |
103 |
Ficolin-2 from the lectin pathway of complement recognizes enteroaggregative Escherichia coli and contributes to innate complement dependent immune protection
|
Sørensen, Camilla Adler |
|
2017 |
89 |
C |
p. 160- 1 p. |
artikel |
104 |
Ficolins do not alter host immune responses to lipopolysaccharide-induced inflammation in vivo
|
Genster, Ninette |
|
2017 |
89 |
C |
p. 163-164 2 p. |
artikel |
105 |
Forms of contact-activated C3 associated with AP convertase formation
|
Fromell, Karin |
|
2017 |
89 |
C |
p. 141- 1 p. |
artikel |
106 |
Functional analysis of AMD-associated rare genetic variants in C9
|
Kremlitzka, Mariann |
|
2017 |
89 |
C |
p. 150- 1 p. |
artikel |
107 |
Functional characterization of alternative pathway C3 and C5 convertase inhibitors
|
Gorham Jr., Ronald D. |
|
2017 |
89 |
C |
p. 141- 1 p. |
artikel |
108 |
Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4
|
Mácsik-Valent, Bernadett |
|
2017 |
89 |
C |
p. 123- 1 p. |
artikel |
109 |
Gain-of-function mutants of complement factor B as standards in functional assay measuring the activity of complement convertases
|
Urban, Aleksandra |
|
2017 |
89 |
C |
p. 118- 1 p. |
artikel |
110 |
Gas embolism during surgery. A complement mediated condition?
|
Storm, Benjamin Stage |
|
2017 |
89 |
C |
p. 193- 1 p. |
artikel |
111 |
Generation of CD46, CD55 and CD59 CRISPR/Cas9 knockout cell lines
|
Gormley, Darren |
|
2017 |
89 |
C |
p. 169- 1 p. |
artikel |
112 |
Genetic association of complement receptors to preeclampsia revealed by targeted exomic sequencing
|
Lokki, A. Inkeri |
|
2017 |
89 |
C |
p. 147-148 2 p. |
artikel |
113 |
Genetic rearrangements in CFH and CFH-Related genes in atypical Hemolytic Uremic Syndrome, C3 glomerulopathy and Immuno-Complex mediated MPGN
|
Piras, Rossella |
|
2017 |
89 |
C |
p. 148- 1 p. |
artikel |
114 |
Hemodialysis patients with cardiovascular event have unfavorable complement profile
|
Costa, M. Gaya da |
|
2017 |
89 |
C |
p. 128- 1 p. |
artikel |
115 |
Heparan sulfate-modifying enzymes differentially determine complement factor H/factor H-related protein binding to glomerular endothelial cells
|
Loeven, Markus A. |
|
2017 |
89 |
C |
p. 177- 1 p. |
artikel |
116 |
High levels of soluble CD59 in CSF compared to plasma suggests intrathecal source of soluble CD59
|
Zelek, Wioleta |
|
2017 |
89 |
C |
p. 186- 1 p. |
artikel |
117 |
HLA study in anti-complement factor H antibody-associated atypical hemolytic uremic syndrome
|
Dragon-Durey, M.-A. |
|
2017 |
89 |
C |
p. 175- 1 p. |
artikel |
118 |
How clinical laboratory standard capillary protein electrophoresis alerted to a low C3 state
|
Hernández-González, Manuel |
|
2017 |
89 |
C |
p. 152- 1 p. |
artikel |
119 |
Human c1q induces apoptosis in an ovarian cancer cell line via tumor necrosis factor pathway
|
Kaur, Anuvinder |
|
2017 |
89 |
C |
p. 124- 1 p. |
artikel |
120 |
Human epithelial C5aR1 signalling enhances bacterial adhesion to renal tubular epithelial cells through upregulation of the expression of mannosyle residues (the ligand for type I fimbrae)
|
Song, Yun |
|
2017 |
89 |
C |
p. 173-174 2 p. |
artikel |
121 |
Impact of carbamylation on IgG mediated complement activation
|
Lubbers, Rosalie |
|
2017 |
89 |
C |
p. 142- 1 p. |
artikel |
122 |
Improved function and in vivo half-life of new homo-dimeric mini-FH constructs in experimental kidney disease
|
Yang, Yi |
|
2017 |
89 |
C |
p. 202- 1 p. |
artikel |
123 |
Increasing endothelial permeability: A novel function of complement MASP-1
|
Debreczeni, Márta Lídia |
|
2017 |
89 |
C |
p. 134- 1 p. |
artikel |
124 |
Independent role of C5aR1 and C5aR2 during acute Toxoplasma gondii infection
|
Mey, Fabian T. |
|
2017 |
89 |
C |
p. 161-162 2 p. |
artikel |
125 |
Inhibiting and activating effects of antimicrobial peptides on complement
|
Berlov, Mikhail N. |
|
2017 |
89 |
C |
p. 195-196 2 p. |
artikel |
126 |
Inhibition of complement alternative pathway by ACH-4471, the first clinical investigational orally-administered inhibitor of complement factor D
|
Huang, Mingjun |
|
2017 |
89 |
C |
p. 200-201 2 p. |
artikel |
127 |
Interaction between multimeric VWF and complement: A fresh look to the pathophysiology of microvascular thrombosis
|
Noris, Marina |
|
2017 |
89 |
C |
p. 133- 1 p. |
artikel |
128 |
Interaction of complement defence collagens C1q and MBL with BMP-1/tolloid-like proteinases
|
Lacroix, Monique |
|
2017 |
89 |
C |
p. 130-131 2 p. |
artikel |
129 |
Interaction of factor H family proteins with DNA and dead cells: Implications for the regulation of opsonization
|
Kárpáti, Éva |
|
2017 |
89 |
C |
p. 140-141 2 p. |
artikel |
130 |
Intracellular complement − the complosome − in immune cell regulation
|
Arbore, Giuseppina |
|
2017 |
89 |
C |
p. 2-9 8 p. |
artikel |
131 |
Intravascular hemolysis induces complement system activation
|
Merle, Nicolas S. |
|
2017 |
89 |
C |
p. 164- 1 p. |
artikel |
132 |
In vitro assessment of xenogeneic complement and endothelial cell activation using a microvascular flow model
|
Sfriso, Riccardo |
|
2017 |
89 |
C |
p. 209- 1 p. |
artikel |
133 |
Kallikrein represents an independent complement activator
|
Irmscher, Sarah |
|
2017 |
89 |
C |
p. 140- 1 p. |
artikel |
134 |
Lectin pathway proteins and association with complement activation and disease activity in patients with Systemic Lupus Erythematosus
|
Troldborg, Anne |
|
2017 |
89 |
C |
p. 117- 1 p. |
artikel |
135 |
Local complement activation in aqueous humor in patients with age-related macular degeneration
|
Kirschfink, Michael |
|
2017 |
89 |
C |
p. 163- 1 p. |
artikel |
136 |
Malaria parasite evasion of classical complement pathway attack
|
Larsen, Mads Delbo |
|
2017 |
89 |
C |
p. 159- 1 p. |
artikel |
137 |
Mannose-binding lectin drives vascular damage and interacts with platelet-derived IL-1α after cerebral ischemia in mice
|
De Simoni, Maria-Grazia |
|
2017 |
89 |
C |
p. 185- 1 p. |
artikel |
138 |
Mapping of ligand binding sites provides insight into the function of factor H-related protein 5
|
Papp, Alexandra |
|
2017 |
89 |
C |
p. 145- 1 p. |
artikel |
139 |
Markers of the lectin-complement pathway in patients with aneurysmal subarachnoid haemorrhage
|
Krogh, Charlotte Loumann |
|
2017 |
89 |
C |
p. 170-171 2 p. |
artikel |
140 |
MASP-3 specifically recognizes different Aspergillus species
|
Rosbjerg, Anne |
|
2017 |
89 |
C |
p. 154- 1 p. |
artikel |
141 |
Monitoring of hemolytic activity of serum during alemtuzumab/ofatumumab therapy of chronic lymphocytic leukemia
|
Stasiłojć, Grzegorz |
|
2017 |
89 |
C |
p. 203- 1 p. |
artikel |
142 |
Monoclonal gammopathy-associated atypical hemolytic uremic syndrome: A relevant concept?
|
Fremeaux-Bacchi, Veronique |
|
2017 |
89 |
C |
p. 172- 1 p. |
artikel |
143 |
Motor neuron disease proteins activate complement and generate C5a
|
Deora, Vandana |
|
2017 |
89 |
C |
p. 168- 1 p. |
artikel |
144 |
Mouse FHRB interacts with renal-bound C3 in vivo: Implications for C3 glomerulopathy
|
Malik, Talat H. |
|
2017 |
89 |
C |
p. 176- 1 p. |
artikel |
145 |
Multimeric FHR4 immunoconjugates promote efficient activation of CAP on Her2 tumour cells, further controlled by overexpressed mCRPs, limiting MAC formation and CDC
|
Plesseria, Jean-Marc |
|
2017 |
89 |
C |
p. 206- 1 p. |
artikel |
146 |
Natural history study of C3 glomerulopathy
|
Lomax-Browne, Hannah J. |
|
2017 |
89 |
C |
p. 176- 1 p. |
artikel |
147 |
Neoepitope based assays to detect C5a – Pitfalls and interpretations
|
Bergseth, Grethe |
|
2017 |
89 |
C |
p. 201- 1 p. |
artikel |
148 |
Neutralization of the potent neurotropic Chandipura virus via classical pathway is dependent on C1q
|
Kunnakkadan, Umerali |
|
2017 |
89 |
C |
p. 153- 1 p. |
artikel |
149 |
New concepts on the therapeutic control of complement anaphylatoxin receptors
|
Hawksworth, Owen A. |
|
2017 |
89 |
C |
p. 36-43 8 p. |
artikel |
150 |
Novel CFHR2 variants: Another nuance in the complex spectrum of kidney disease aHUS and C3GN
|
Stea, Emma D. |
|
2017 |
89 |
C |
p. 179- 1 p. |
artikel |
151 |
Novel duplication of the FHRs dimerization domain associated with C3G
|
Tortajada, Agustín |
|
2017 |
89 |
C |
p. 181- 1 p. |
artikel |
152 |
Novel insights into the expression pattern of anaphylatoxin receptors in mice and men
|
Laumonnier, Yves |
|
2017 |
89 |
C |
p. 44-58 15 p. |
artikel |
153 |
Pathogenic mutations in C1R and C1S: In quest for molecular mechanisms
|
Christine, Gaboriaud |
|
2017 |
89 |
C |
p. 188-189 2 p. |
artikel |
154 |
Pentraxins PTX3 and CRP recruit C1q to cholesterol crystals and co-localize with the terminal complement complex in human atherosclerotic plaques
|
Pilely, Katrine |
|
2017 |
89 |
C |
p. 126-127 2 p. |
artikel |
155 |
Peritoneal eosinophils increase during induction of peritoneal dialysis and may be related to production of C3a in peritoneal dialysate
|
Mizuno, Masashi |
|
2017 |
89 |
C |
p. 193- 1 p. |
artikel |
156 |
Permeability of Bruch's membrane to complement proteins: Implications for translational medicine in AMD
|
Clark, Simon J. |
|
2017 |
89 |
C |
p. 200- 1 p. |
artikel |
157 |
Phenotypic studies of a novel factor B mutation in familial atypical hemolytic uremic syndrome
|
Aradottir, Sigridur Sunna |
|
2017 |
89 |
C |
p. 182- 1 p. |
artikel |
158 |
Plasma C4d as marker for lupus nephritis in Systemic Lupus Erythematosus
|
Martin, Myriam |
|
2017 |
89 |
C |
p. 115-116 2 p. |
artikel |
159 |
Plasma levels of lectin pathway components in IgA nephropathy
|
Medjeral-Thomas, Nicholas R. |
|
2017 |
89 |
C |
p. 178- 1 p. |
artikel |
160 |
Post-translational modification of complement anaphylatoxins during chronic neutrophilic inflammation
|
Stott, Matthew |
|
2017 |
89 |
C |
p. 167- 1 p. |
artikel |
161 |
Preface 16th European Meeting of Complement in Human Disease, Copenhagen, Denmark, September 8th-12th 2017
|
|
|
2017 |
89 |
C |
p. 1- 1 p. |
artikel |
162 |
Quantitative Western-blot profiles of factor H and factor H-related proteins in atypical haemolytic uraemic syndrome and C3 glomerulopathy
|
Gómez, Irene |
|
2017 |
89 |
C |
p. 181- 1 p. |
artikel |
163 |
RA101495 abolishes residual complement activity observed in the presence of eculizumab
|
Ricardo, Alonso |
|
2017 |
89 |
C |
p. 189- 1 p. |
artikel |
164 |
Reduction of myocardial ischemia reperfusion injury in pigs by (over) expression of human membrane co-factor protein
|
Abdelhafez, Mai |
|
2017 |
89 |
C |
p. 129- 1 p. |
artikel |
165 |
Relationship between CFHR5 and complement parameters in patients suffering from complement-mediated kidney disorders, with or without CFHR5 mutations
|
Csuka, Dorottya |
|
2017 |
89 |
C |
p. 177- 1 p. |
artikel |
166 |
Role of complement in cancer-related inflammation
|
Di Marco, Sabrina |
|
2017 |
89 |
C |
p. 124- 1 p. |
artikel |
167 |
Role of complement in cancer-related inflammation
|
Magrini, Elena |
|
2017 |
89 |
C |
p. 121-122 2 p. |
artikel |
168 |
Role of monoclonal and polyclonal immunoglobulins in AP dysregulation in C3 glomerulopathy associated with monoclonal gammopathy
|
Chauvet, Sophie |
|
2017 |
89 |
C |
p. 174- 1 p. |
artikel |
169 |
Role of the complement system in the inflammatory process caused by a class P1 metalloproteinase from Bothrops pirajai venom: Analysis in the ex vivo model of human whole blood
|
Luchini, Lygia S.G. |
|
2017 |
89 |
C |
p. 166- 1 p. |
artikel |
170 |
SALSA—A dance on a slippery floor with changing partners
|
Reichhardt, M.P. |
|
2017 |
89 |
C |
p. 100-110 11 p. |
artikel |
171 |
SALSA – Step by step
|
Reichhardt, Martin Parnov |
|
2017 |
89 |
C |
p. 197- 1 p. |
artikel |
172 |
Simultaneous determination of C1-INH-containing activation complexes in human plasma
|
Kajdácsi, Erika |
|
2017 |
89 |
C |
p. 137-138 2 p. |
artikel |
173 |
siRNA-mediated targeting of hepatocyte mannan-binding lectin-associated serine protease-3 for the treatment of murine collagen-antibody-inducsed arthritis (CAIA), a model for human rheumatoid arthritis
|
Banda, Nirmal K. |
|
2017 |
89 |
C |
p. 161- 1 p. |
artikel |
174 |
Structural and functional studies of human complement factor P
|
Pedersen, Dennis V. |
|
2017 |
89 |
C |
p. 197-198 2 p. |
artikel |
175 |
Structural studies of convertases in the complement system. The properdin-stabilised proconvertase, and the C5 convertase
|
Gadeberg, Trine A.F. |
|
2017 |
89 |
C |
p. 198- 1 p. |
artikel |
176 |
Systemic- and local complement activation controls the NLRP3 inflammasome pathway in patients with atherosclerosis
|
Espevik, Terje |
|
2017 |
89 |
C |
p. 125-126 2 p. |
artikel |
177 |
Systemic complement activation 3–6h after trauma predicts patient outcome
|
Pischke, Soeren E. |
|
2017 |
89 |
C |
p. 212- 1 p. |
artikel |
178 |
Targeted C4 inhibition by affinity purified immunoglobulins
|
Volokhina, Elena |
|
2017 |
89 |
C |
p. 201-202 2 p. |
artikel |
179 |
Targeted nanoparticles and complement activation
|
Macor, Paolo |
|
2017 |
89 |
C |
p. 204- 1 p. |
artikel |
180 |
The activated form of complement MASP-3 is the major variant in resting blood
|
Dobó, József |
|
2017 |
89 |
C |
p. 194-195 2 p. |
artikel |
181 |
The alternative complement pathway is dysregulated in patients with chronic heart failure
|
Shahini, Negar |
|
2017 |
89 |
C |
p. 127- 1 p. |
artikel |
182 |
The C5a/C5aR1 axis controls the development of Epidermolysis bullosa acquisita through its impact on IgG autoantibody formation and glycosylation
|
Kovács, Bálint |
|
2017 |
89 |
C |
p. 134- 1 p. |
artikel |
183 |
The effect of complement inhibition on erythrocyte destruction in AIHA
|
Baas, Inge |
|
2017 |
89 |
C |
p. 203- 1 p. |
artikel |
184 |
The Factor H splice variant FHL-1 contributes substantially to alternative pathway regulation, but is not specific for the host marker sialic acid
|
Schmidt, Christoph Q. |
|
2017 |
89 |
C |
p. 195- 1 p. |
artikel |
185 |
The human complement system sensitizes Gram-negative bacteria for Gram-positive-specific antibiotics via pore formation in the outer membrane
|
Bardoel, B.W. |
|
2017 |
89 |
C |
p. 155- 1 p. |
artikel |
186 |
The IL-6 receptor inhibitor tocilizumab attenuated expression of C5a receptor 1 and 2 in patients with myocardial infarction
|
Orrem, Hilde L. |
|
2017 |
89 |
C |
p. 128- 1 p. |
artikel |
187 |
The intracellular C5 system is critical to DAMP sensing and cellular responses in human monocytes
|
Niyonzima, Nathalie |
|
2017 |
89 |
C |
p. 131- 1 p. |
artikel |
188 |
The link between morphology and complement in ocular disease
|
Mohlin, Camilla |
|
2017 |
89 |
C |
p. 84-99 16 p. |
artikel |
189 |
The murine factor H-related protein FHR-B promotes complement activation
|
Cserhalmi, Marcell |
|
2017 |
89 |
C |
p. 142-143 2 p. |
artikel |
190 |
Therapy with eculizumab for patients with primary p.Cys89Tyr mutation in the CD59 gene avoids recurrent arterial thrombosis
|
Mevorach, Dror |
|
2017 |
89 |
C |
p. 186- 1 p. |
artikel |
191 |
Thermodynamics of the complex formation between Mannan-binding lectin and MASPs
|
Schatz-Jakobsen, Janus A. |
|
2017 |
89 |
C |
p. 144- 1 p. |
artikel |
192 |
The role of C5 convertases in membrane attack complex dependent killing of Gram-negative bacteria
|
Heesterbeek, D.A.C. |
|
2017 |
89 |
C |
p. 154- 1 p. |
artikel |
193 |
The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes
|
Lukácsi, Szilvia |
|
2017 |
89 |
C |
p. 144-145 2 p. |
artikel |
194 |
The role of the complement system in hereditary angioedema
|
Csuka, Dorottya |
|
2017 |
89 |
C |
p. 59-68 10 p. |
artikel |
195 |
The spectrum of complement C9 staining in lupus nephritis
|
Wilson, Hannah R. |
|
2017 |
89 |
C |
p. 179- 1 p. |
artikel |
196 |
Treating C3G murine models by mini-Factor H
|
Keenan, Adam |
|
2017 |
89 |
C |
p. 205- 1 p. |
artikel |
197 |
Treatment of experimental C3 Glomerulopathy by human complement factor H produced in glycosylation-optimized Physcomitrella patens
|
Häffner, Karsten |
|
2017 |
89 |
C |
p. 120- 1 p. |
artikel |
198 |
Treatment of the C3 gain-of-function mouse model of aHUS with BB5.1, TT30 or genetic deletion of C5
|
Smith-Jackson, Kate |
|
2017 |
89 |
C |
p. 180- 1 p. |
artikel |
199 |
Ultra-rare C3 mutation leading to a dominant familial C3 glomerulopathy phenotype
|
Leonhardt, Alexandria |
|
2017 |
89 |
C |
p. 175-176 2 p. |
artikel |
200 |
Unraveling the role of the glomerular glycomatrix in C3 glomerulopathy
|
Hauer, Jill |
|
2017 |
89 |
C |
p. 183- 1 p. |
artikel |
201 |
Unravelling the pathophysiology of C3G/IC-MPGN and how to predict disease progression and orient therapies
|
Iatropoulos, Paraskevas |
|
2017 |
89 |
C |
p. 178- 1 p. |
artikel |
202 |
Utilising Staphylococcus aureus immune evasion protein Sbi as a novel vaccine conjugate
|
Back, Catherine R. |
|
2017 |
89 |
C |
p. 199- 1 p. |
artikel |
203 |
Validation of complement Factor H function assay and assessment of patients diagnosed with aHUS
|
Dennis, Jaclyn |
|
2017 |
89 |
C |
p. 145-146 2 p. |
artikel |
204 |
Variable biological properties of two different preparations of Shiga toxins yielding new insights into eHUS pathogenesis
|
Chatterjee, Sneha |
|
2017 |
89 |
C |
p. 159- 1 p. |
artikel |
205 |
Whole exome sequencing in diagnostics of atypical hemolytic uremic syndrome
|
Koskinen, Aino R. |
|
2017 |
89 |
C |
p. 148-149 2 p. |
artikel |